JP2012518389A - Ｇｉ癌の転移を検出するための方法 - Google Patents

Ｇｉ癌の転移を検出するための方法 Download PDF

Info

Publication number
JP2012518389A
JP2012518389A JP2011550395A JP2011550395A JP2012518389A JP 2012518389 A JP2012518389 A JP 2012518389A JP 2011550395 A JP2011550395 A JP 2011550395A JP 2011550395 A JP2011550395 A JP 2011550395A JP 2012518389 A JP2012518389 A JP 2012518389A
Authority
JP
Japan
Prior art keywords
gcc
cancer
gusb
sample
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011550395A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012518389A5 (https=
Inventor
ジャン フランソワ アンス
ギヨーム ボードリー
ジュヌヴィエーヴ ガロン
ミシェル ウドゥ
ティモシー ジェイ ホルツァー
マーテン ボーリュ
ニコラ ベルトラン
Original Assignee
ダイアグノキュア インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダイアグノキュア インコーポレイテッド filed Critical ダイアグノキュア インコーポレイテッド
Publication of JP2012518389A publication Critical patent/JP2012518389A/ja
Publication of JP2012518389A5 publication Critical patent/JP2012518389A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2011550395A 2009-02-25 2010-02-24 Ｇｉ癌の転移を検出するための方法 Pending JP2012518389A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15517209P 2009-02-25 2009-02-25
US61/155,172 2009-02-25
US24619709P 2009-09-28 2009-09-28
US61/246,197 2009-09-28
PCT/CA2010/000277 WO2010096929A1 (en) 2009-02-25 2010-02-24 Method for detecting metastasis of gi cancer

Publications (2)

Publication Number Publication Date
JP2012518389A true JP2012518389A (ja) 2012-08-16
JP2012518389A5 JP2012518389A5 (https=) 2013-04-04

Family

ID=42664977

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011550395A Pending JP2012518389A (ja) 2009-02-25 2010-02-24 Ｇｉ癌の転移を検出するための方法

Country Status (7)

Country Link
US (1) US20110306055A1 (https=)
EP (2) EP2677036A3 (https=)
JP (1) JP2012518389A (https=)
CN (1) CN102333887B (https=)
AU (1) AU2010217160C1 (https=)
CA (1) CA2752668A1 (https=)
WO (1) WO2010096929A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY173390A (en) 2009-10-23 2020-01-22 Takeda Pharmaceuticals Co Anti-gcc antibody molecules and related compositions and methods
US9416410B2 (en) * 2012-02-14 2016-08-16 Genetics Development Corporation Cutoff point delta Ct. method for HER2 PCR testing in breast cancer
ME03560B (me) 2012-04-27 2020-07-20 Millennium Pharm Inc MOLEKULI ANTI-GCC ANTITELA l NJIHOVA UPOTREBA U ISPITIVANJU OSETLJIVOSTI NA GCC-CILJANU TERAPIJU
WO2016028141A1 (en) * 2014-08-18 2016-02-25 Universiti Kebangsaan Malaysia Method for determining prognosis of colorectal cancer
EP4706525A3 (en) 2014-09-25 2026-04-22 BT Bidco, Inc. Electromechanical pill device with localization capabilities
EP3500177A1 (en) * 2016-08-18 2019-06-26 Mitchell Lawrence Jones Systems for obtaining samples using ingestible devices
KR20230042759A (ko) 2016-09-09 2023-03-29 비오라 쎄라퓨틱스, 인크. 분배가능한 물질의 전달을 위한 전자기계식 섭취가능한 디바이스
US10610104B2 (en) 2016-12-07 2020-04-07 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
US11761032B2 (en) * 2017-03-11 2023-09-19 Yan Wang Methods and devices for performing real time digital PCR
EP3900613B1 (en) 2017-03-31 2023-12-27 Biora Therapeutics, Inc. Localization methods for an ingestible device
US20220249814A1 (en) 2018-11-19 2022-08-11 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
CN110819715A (zh) * 2019-11-26 2020-02-21 华夏帮服科技有限公司 用于结直肠癌检测的免疫基因标志物及试剂盒
CN118460719A (zh) * 2020-03-02 2024-08-09 腾辰生物科技(上海)有限公司 一种分子标志物及试剂盒在辅助诊断食管癌中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008508861A (ja) * 2004-05-18 2008-03-27 ガニュメート・ファーマシューティカルズ・アクチェンゲゼルシャフト 腫瘍で差次的に発現する遺伝子産物及びその用途
WO2008045133A2 (en) * 2006-03-03 2008-04-17 Veridex, Llc Molecular assay to predict recurrence of dukes' b colon cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601990A (en) 1994-09-13 1997-02-11 Thomas Jefferson University Methods of diagnosing colorectal tumors and metastasis thereof
EP0734264B1 (en) 1993-10-26 2004-02-18 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
WO1997042506A1 (en) 1996-05-03 1997-11-13 Thomas Jefferson University Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof
US7135333B1 (en) 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US6120995A (en) 1997-08-07 2000-09-19 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
AU2001249548A1 (en) 2000-03-27 2001-10-08 Thomas Jefferson University Compositions and methods for identifying and targeting cancer cells
US7138226B2 (en) 2002-05-10 2006-11-21 The University Of Miami Preservation of RNA and morphology in cells and tissues
US20040018494A1 (en) * 2002-07-25 2004-01-29 Shurtliff Roxanne N Isothermal transcription based amplification assay for detection and quantification of guanylyl cyclase C

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008508861A (ja) * 2004-05-18 2008-03-27 ガニュメート・ファーマシューティカルズ・アクチェンゲゼルシャフト 腫瘍で差次的に発現する遺伝子産物及びその用途
WO2008045133A2 (en) * 2006-03-03 2008-04-17 Veridex, Llc Molecular assay to predict recurrence of dukes' b colon cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6014030094; Ｃｌｉｎ．　Ｃａｎｃｅｒ　Ｒｅｓ． Ｖｏｌ．１２，Ｎｏ．１５, 2006, ｐ４５４５-４５５２ *
JPN6014030095; ＤＮＡチップとリアルタイムＰＣＲ , 2006, ｐ１５７-１６３ *
JPN6014030096; Ｍｏｌ．　Ａｓｐｅｃｔｓ　Ｍｅｄ． Ｖｏｌ．２７, 2006, ｐ１９２-２２３ *
JPN6014030097; Ｓｔａｔｉｓ．　ｉｎ　Ｍｅｄ． Ｖｏｌ．２６, 2007, ｐ５５９６-５６１１ *

Also Published As

Publication number Publication date
EP2401394B1 (en) 2013-11-27
CN102333887A (zh) 2012-01-25
EP2677036A2 (en) 2013-12-25
EP2677036A3 (en) 2014-01-22
CA2752668A1 (en) 2010-09-02
AU2010217160C1 (en) 2015-07-02
HK1165836A1 (en) 2012-10-12
WO2010096929A1 (en) 2010-09-02
EP2401394A1 (en) 2012-01-04
US20110306055A1 (en) 2011-12-15
AU2010217160B2 (en) 2014-11-20
EP2401394A4 (en) 2012-07-11
CN102333887B (zh) 2014-04-02
AU2010217160A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
CN102333887B (zh) 用于检测gi癌转移的方法
ES2741745T3 (es) Método para usar la expresión génica para determinar el pronóstico de cáncer de próstata
US9416410B2 (en) Cutoff point delta Ct. method for HER2 PCR testing in breast cancer
US20110318742A1 (en) Micro rna markers for colorectal cancer
US20130323740A1 (en) Direct blood assay for detection of circulating microrna in cancer patients
US20110027784A1 (en) Novel Primers for Identification of Astrocytoma, Its Grades and Glioblastoma Prognosis
US20130303400A1 (en) Multimarker panel
JP6608424B2 (ja) 前癌性結腸直腸ポリープおよび結腸直腸癌を特定するための方法およびキット
Iverson et al. A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens
KR102036222B1 (ko) 당뇨병성 신증에 의한 만성신장질환 환자의 예후 예측용 마커
EP4073274A1 (en) A new method for diagnosing a thyroid tumour and kit thereof
EP2550534A1 (en) Prognosis of oesophageal and gastro-oesophageal junctional cancer
CN108424962B (zh) 系膜增生性肾小球肾炎的miRNA检测标志物及其诊断试剂盒
US20170335399A1 (en) Detection of mineralocorticoid receptor activation and personalized antihypertensive therapy based thereon
US20110287958A1 (en) Method for Using Gene Expression to Determine Colorectal Tumor Stage
US20180010191A1 (en) Cutoff point delta ct method for genetic pcr testing in human cancer
KR102036221B1 (ko) 만성신장질환의 예후 예측을 위한 후성 유전학적 진단 키트 개발
KR102036219B1 (ko) 유전자 프로모터의 CpG 메틸화 변화를 이용한 만성신장질환의 악화 예측용 조성물 및 이의 이용
KR102036220B1 (ko) 만성신장질환 특이적 후성학적 메틸화 마커 검출용 조성물 및 검출방법
HK1165836B (en) Method for detecting metastasis of gi cancer
JP2014527816A (ja) 初期卵巣がんの検出マーカーとしての精子タンパク質
BRPI1003742B1 (pt) Uso combinado de técnicas e biomarcadores moleculares para monitoramento e diagnóstico do câncer de próstata

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130218

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150421

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150706

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160119